Answers are grounded in this paper and cite their sources.
The biosynthesis of 4-hydroxy-3-nitrosobenzamide in Streptomyces murayamaensis mutants MC2 and MC3 has been studied using sodium [1,2- 13 C 2 ]- and [1- 13 C, 18 O 2 ]acetate, sodium [2,3- 13 C 2 ]succinate, [1,2- 13 C 2 ]glutamic acid, [4- 13 C]aspartic acid, and sodium [1- 13 C]- and [2,3- 13 C 2 ]pyruvate. 13 C NMR analysis of the labeling patterns from the first two of these suggested a pathway via condensation of a four-carbon unit from the tricarboxylic acid (TCA) cycle with a three-carbon unit, possibly phosphoenol pyruvate. Subsequent specific incorporations of the labeled succinic acid, aspartic acid, and glutamic acid confirmed the TCA cycle involvement and the orientation of the four-carbon intermediate. Specific incorporation of the labeled pyruvic acids confirmed the involvement of a three-carbon unit and defined its orientation. This is the first aminohydroxybenzoic acid derivative shown not to be derived from a shikimic acid-type pathway, and its origin provides a rationale for the biosynthesis of other microbial products such as asukamycin, manumycin, and the michigazones.
No takes yet. Share an insight, caveat, or question.
Gould et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: